Cost Savings

Systematic and Multimodality Approach

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (opens new window)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn, DR

Source‎: Anaesthesia 2019;74(12):1534-41.

Indexed‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Source‎: Blood Adv. 2022;6(3):785-92.

Indexed‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (opens new window)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (opens new window)

Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.

Source‎: Transfusion 2017;57(9):2189-96.

Indexed‎: PubMed 28671296

DOI‎: 10.1111/trf.14191

https://www.ncbi.nlm.nih.gov/pubmed/28671296 (opens new window)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (opens new window)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Source‎: Transfusion 2015;55(12):2807-15.

Indexed‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (opens new window)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (opens new window)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Source‎: Transfusion 2010;50(2):487-92.

Indexed‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (opens new window)

Anemia Management

Should intravenous iron be the standard of care in oncology? (opens new window)

Auerbach M.

Source‎: J Clin Oncol 2008;26(10):1579-81.

Indexed‎: PubMed 18375888

DOI‎: 10.1200/JCO.2007.15.4609

https://www.ncbi.nlm.nih.gov/pubmed/18375888 (opens new window)

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (opens new window)

Beverina I, Razionale G, Ranzini M, Aloni A, Finazzi S, Brando B.

Source‎: Blood Transfus 2020;18(2):106-16.

Indexed‎: PubMed 31855149

DOI‎: 10.2450/2019.0248-19

https://www.ncbi.nlm.nih.gov/pubmed/31855149 (opens new window)

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (opens new window)

Borg S, Glenngård AH, Osterborg A, Persson U.

Source‎: Acta Oncol 2008;47(6):1009-17.

Indexed‎: PubMed 18770060

DOI‎: 10.1080/02841860701744498

https://www.ncbi.nlm.nih.gov/pubmed/18770060 (opens new window)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (opens new window)

Deger M, Eisterer W, Kutikova L, Salek S.

Source‎: Support Care Cancer 2013;21(2):485-93.

Indexed‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

https://www.ncbi.nlm.nih.gov/pubmed/22825456 (opens new window)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (opens new window)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Source‎: Cancer 2013;119(1):107-14.

Indexed‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (opens new window)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (opens new window)

Nikolaidi E, Hatzikou M, Geitona M.

Source‎: Cost Eff Resour Alloc 2013;11(1):16.

Indexed‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (opens new window)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (opens new window)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Source‎: Support Care Cancer 2012;20(1):159-65.

Indexed‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (opens new window)

Hemostatic Agents

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (opens new window)

Guest JF, Watson HG, Limaye S.

Source‎: Clin Ther 2010;32(14):2478-93.

Indexed‎: PubMed 21353116

DOI‎: 10.1016/j.clinthera.2011.01.011

https://www.ncbi.nlm.nih.gov/pubmed/21353116 (opens new window)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (opens new window)

Jen H, Shew S.

Source‎: J Pediatr Surg 2008;43(12):2235-8.

Indexed‎: PubMed 19040942

DOI‎: 10.1016/j.jpedsurg.2008.08.053

https://www.ncbi.nlm.nih.gov/pubmed/19040942 (opens new window)

Periprocedural/Intraoperative Blood Conservation and Blood Management

Restrictive blood transfusion practices are associated with improved patient outcomes. (opens new window)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Source‎: Transfusion 2014;54(10 Pt 2):2753-9.

Indexed‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (opens new window)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (opens new window)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Source‎: Hematology 2018;23(7):417-22.

Indexed‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (opens new window)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (opens new window)

Stallworth JR, Jerrell JM, Tripathi A.

Source‎: Am J Hematol 2010;85(10):795-7.

Indexed‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (opens new window)

HEMATOLOGY AND ONCOLOGY

Cost Savings

English

Cost Savings

/assets/ct/fa66d95d54/images/syn_placeholder_sqr.png

Systematic and Multimodality Approach

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (opens new window)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (opens new window)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (opens new window)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (opens new window)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (opens new window)

Anemia Management

Should intravenous iron be the standard of care in oncology? (opens new window)

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (opens new window)

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (opens new window)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (opens new window)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (opens new window)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (opens new window)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (opens new window)

Hemostatic Agents

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (opens new window)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (opens new window)

Periprocedural/Intraoperative Blood Conservation and Blood Management

Restrictive blood transfusion practices are associated with improved patient outcomes. (opens new window)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (opens new window)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (opens new window)

Hospital Liaison Committee (HLC)

Medical Information Packets

Videos

Cost Savings

Systematic and Multimodality Approach

Anemia Management

Hemostatic Agents

Periprocedural/Intraoperative Blood Conservation and Blood Management

Select Your Language